SCHEMBL5021694

SCHEMBL5021694

O=C1c2ccccc2Cc2cc3c(cc21)Cc1ccccc1C3=O

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.82
CES1 P23141 2/20 0.61
BCHE P06276 1/20 0.61
TDP1 Q9NUW8 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
ALDH1A1 P00352 4/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52
KDM4E B2RXH2 3/20 0.50
MAPT P10636 2/20 0.50
NPC1 O15118 1/20 0.50
LMNA P02545 1/20 0.50
HPGD P15428 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
MIF P14174 1/20 0.48
MAOB P27338 1/20 0.48
SRD5A2 P31213 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6057371 0.93 MAOA (0.78) MAOACES1BCHETDP1L3MBTL1
Anthrone SCHEMBL1527782 0.91 MAOA (1.00) MAOACES1BCHETDP1L3MBTL1
Anthrone SCHEMBL18143 0.91 MAOA (1.00) MAOACES1BCHETDP1L3MBTL1
Anthrone SCHEMBL29448801 0.91 MAOA (1.00) MAOACES1BCHETDP1L3MBTL1
Anthrone SCHEMBL29357010 0.91 MAOA (1.00) MAOACES1BCHETDP1L3MBTL1
SCHEMBL27694768 0.89 MAOA (0.64) MAOACES1BCHETDP1L3MBTL1
Anthrone SCHEMBL30922196 0.88 MAOA (0.95) MAOACES1BCHETDP1L3MBTL1
Anthraquinone SCHEMBL22026730 0.88 MAOA (0.95) MAOACES1BCHETDP1L3MBTL1
Anthrone SCHEMBL22574797 0.88 MAOA (0.95) MAOACES1BCHETDP1L3MBTL1
Anthrone SCHEMBL31385560 0.88 MAOA (0.95) MAOACES1BCHETDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8557953-B2 Polymers comprising substituted anthracenyl units, blends comprising these polymers, and devices comprising these polymers or blends MERCK PATENT GMBH (DE) 2013-10-15 US disclosed
US-20120108731-A1 POLYMERS COMPRISING SUBSTITUTED ANTHRACENYL UNITS, BLENDS COMPRISING THESE POLYMERS, AND DEVICES COMPRISING THESE POLYMERS OR BLENDS MERCK PATENT GMBH (DE) 2012-05-03 US disclosed
US-7892454-B2 Such as 2,3:6,7-anthracenedicarboximide derivatives; air stability, solution processability; n type; organic thin film transistors, light emitting diodes and photovoltaic devices; long lasting POLYERA CORPORATION (US) 2011-02-22 US disclosed
US-7892454-B2 Such as 2,3:6,7-anthracenedicarboximide derivatives; air stability, solution processability; n type; organic thin film transistors, light emitting diodes and photovoltaic devices; long lasting POLYERA CORPORATION (US) 2011-02-22 US disclosed
US-20090297712-A1 Ink Composition Containing Magenta Solid Solution Pigment and Ink jet Recording Method Using the Same SEIKO EPSON CORPORATION (JP) 2009-12-03 US disclosed
US-20090297712-A1 Ink Composition Containing Magenta Solid Solution Pigment and Ink jet Recording Method Using the Same SEIKO EPSON CORPORATION (JP) 2009-12-03 US disclosed
US-20080185555-A1 Acene-based organic semiconductor materials and methods of preparing and using the same USINVEST LLC 2008-08-07 US disclosed
US-20080185555-A1 Acene-based organic semiconductor materials and methods of preparing and using the same USINVEST LLC 2008-08-07 US disclosed
WO-2008063583-A1 ACENE-BASED ORGANIC SEMICONDUCTOR MATERIALS AND METHODS OF PREPARING AND USING THE SAME POLYERA CORPORATION (US) 2008-05-29 WO disclosed
EP-1433211-B1 SUBSTITUTED PENTACENE SEMICONDUCTORS 3M INNOVATIVE PROPERTIES CO (US) 2006-06-21 EP disclosed
US-6864396-B2 Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-03-08 US disclosed
EP-1481428-A1 ORGANIC THIN FILM TRANSISTOR WITH MODIFIED SURFACE OF GATE-DIELECTRIC 3M Innovative Properties Company (US) 2004-12-01 EP disclosed
US-6768132-B2 MULTILAYER INTEGRATED CIRCUIT; BARRIER DIELECTRIC AND SEMICONDUCTOR 3M INNOVATIVE PROPERTIES COMPANY 2004-07-27 US disclosed
EP-1430008-A2 PROCESS FOR PREPARING PENTACENE DERIVATIVES 3M Innovative Properties Company (US) 2004-06-23 EP disclosed
US-20030175551-A1 Surface modified organic thin film transistors 3M INNOVATIVE PROPERTIES COMPANY 2003-09-18 US disclosed
WO-2003077327-A1 ORGANIC THIN FILM TRANSISTORS WITH MODIFIED SURFACE OF GATE-DIELECTRIC 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-09-18 WO disclosed
US-20030105365-A1 Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors 3M INNOVATIVE PROPERTIES COMPANY 2003-06-05 US disclosed
US-20030100779-A1 Process for preparing pentacene derivatives 3M INNOVATIVE PROPERTIES COMPANY 2003-05-29 US disclosed
US-20030097010-A1 Process for preparing pentacene derivatives 3M INNOVATIVE PROPERTIES COMPANY 2003-05-22 US disclosed
WO-2003027050-A2 PROCESS FOR PREPARING PENTACENE DERIVATIVES 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030097010-A1 Process for preparing pentacene derivatives H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PCBP1, RARA MAOA 2558/4885CES1 2841/4885BCHE 4238/4885
US-20030105365-A1 Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors ETV1, HTR3C, SLC43A1 MAOA 411/4885CES1 1925/4885BCHE 3259/4885
US-20080185555-A1 Acene-based organic semiconductor materials and methods of preparing and using the same ACE, ACE2, AGT MAOA 143/4885CES1 3074/4885BCHE 253/4885
US-20030100779-A1 Process for preparing pentacene derivatives H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PCBP1, RARA MAOA 2558/4885CES1 2841/4885BCHE 4238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.